FluxPoint Uranium Conversion Facility
The owner, status and timeline of this project. A free account opens every field.
Source: Nuclear Engineering International
FluxPoint Energy is developing the first new US uranium conversion facility in over 70 years to establish a fully American, vertically integrated nuclear fuel capability. The facility will convert uranium oxide into uranium hexafluoride (UF6), a key step in nuclear fuel production, targeting production start in 2030-2031.
- Status
- Prospective
- Sector
- Nuclear
- Location
- Houston, Texas, United States of America
- Updated
- 22 Jul 2026
- Source
- Nuclear Engineering International
ConstructChat
Ask ConstructChat about FluxPoint Uranium Conversion Facility
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | under development |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | FluxPoint Energy is developing the first new US uranium conversion facility in over 70 years to establish a fully American, vertically integrated nuclear fuel capability. The facility will convert uranium oxide into uranium hexafluoride (UF6), a key step in nuclear fuel production, targeting production start in 2030-2031. |
Original sector | Energy |
Location
Country | United States of America (USA) |
State | Texas |
City | Houston |
Source
Source | Nuclear Engineering International |
URL |
More Details
Record type | Project |
Sector | Nuclear |
Article published date | 2026-04-02 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Nuclear projects in United States
- Barksdale Air Force Base, Louisiana
- Kings Bay Naval Submarine Base
- Gatorade Plant, Pepsi Co, Oklahoma
- ImClone Systems Biopharmaceutical Plant, New Jersey, US
- Novavax Vaccine Plant
- Gibbs Cancer Centre and Research Institute, Pelham, South Carolina
- Hovione API Facility Expansion, East Windsor, New Jersey
- Cascade Chemistry’s Manufacturing Facility Expansion, Eugene
